Pursuant to Regulation 46 & 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Strides Pharma Science has informed it enclosed the link of audio recording of earnings call pertaining to the financial results of the company for the quarter and nine months ended December 31, 2022 held on Tuesday, January 24, 2023. The Results were approved by the Board at its meeting held on January 24, 2023. The same can also be accessed on the Company’s website at: https://www.strides.com/investor-annualreport.html.
The above information is a part of company’s filings submitted to BSE.
